SCHEMBL17233514

SCHEMBL17233514

O=C(NC1CC1)c1nn(-c2cccc(C#Cc3ccc[n+]([O-])c3)c2)c2ncccc2c1=O

nearest known ligand 0.73

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 8/20 0.73
PDE4A P27815 8/20 0.73
PDE4B Q07343 8/20 0.73
PDE4D Q08499 8/20 0.73
PDE4C Q08493 7/20 0.73
CYP2C9 P11712 2/20 0.73
MAP3K14 Q99558 3/20 0.43
PKD1 P98161 2/20 0.43
ELANE P08246 1/20 0.42
RIPK1 Q13546 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17243928 0.92 PDE4B (0.61) KCNH2PDE4APDE4BPDE4DPDE4C
SCHEMBL17243638 0.89 KCNH2 (0.59) KCNH2PDE4APDE4BPDE4DPDE4C
SCHEMBL17233511 0.86 KCNH2 (0.71) KCNH2PDE4APDE4BPDE4DPDE4C
SCHEMBL17243620 0.86 PDE4A (0.54) KCNH2PDE4APDE4BPDE4DPDE4C
SCHEMBL17243619 0.86 PDE4B (0.54) KCNH2PDE4APDE4BPDE4DPDE4C
SCHEMBL17243615 0.85 PDE4A (0.53) KCNH2PDE4APDE4BPDE4DPDE4C
SCHEMBL17243624 0.85 PDE4A (0.53) KCNH2PDE4APDE4BPDE4DPDE4C
SCHEMBL17243923 0.85 KCNH2 (0.57) KCNH2PDE4APDE4BPDE4DPDE4C
SCHEMBL17243929 0.85 KCNH2 (0.57) KCNH2PDE4APDE4BPDE4DPDE4C
Mk-0873 SCHEMBL4950462 0.84 PDE4A (1.00) KCNH2PDE4APDE4BPDE4DPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181244-B1 Substituted pyrido[2,3-c]pyridazin-4(1H)-ones as tumor necrosis factor alpha and phosphodiesterase 4 inhibitors Xuanzhu Pharma Co., Ltd. (CN) 2015-11-10 US disclosed
US-9181244-B1 Substituted pyrido[2,3-c]pyridazin-4(1H)-ones as tumor necrosis factor alpha and phosphodiesterase 4 inhibitors Xuanzhu Pharma Co., Ltd. (CN) 2015-11-10 US disclosed